Cargando…

Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers

MicroRNAs (miRNAs) are short noncoding RNAs that post-transcriptionally regulate gene expression and play important roles in various physiological and developmental processes such as oncogenic or tumor suppressive regulators. Specific miRNA expression signatures have been identified in a number of h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawaguchi, Tsutomu, Komatsu, Shuhei, Ichikawa, Daisuke, Tsujiura, Masahiro, Takeshita, Hiroki, Hirajima, Shoji, Miyamae, Mahito, Okajima, Wataru, Ohashi, Takuma, Imamura, Taisuke, Kiuchi, Jun, Konishi, Hirotaka, Shiozaki, Atsushi, Okamoto, Kazuma, Otsuji, Eigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037738/ https://www.ncbi.nlm.nih.gov/pubmed/27598137 http://dx.doi.org/10.3390/ijms17091459

Ejemplares similares

Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
por: Miyamae, Mahito, et al.
Publicado: (2015)

Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma
por: Komatsu, Shuhei, et al.
Publicado: (2016)

Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function
por: Okajima, Wataru, et al.
Publicado: (2016)

Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma
por: Kobayashi, Hiroki, et al.
Publicado: (2015)

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)

Low plasma levels of miR-101 are associated with tumor progression in gastric cancer
por: Imamura, Taisuke, et al.
Publicado: (2017)

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
por: Okajima, Wataru, et al.
Publicado: (2017)

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction
por: Aratani, Kenichi, et al.
Publicado: (2017)

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer
por: Imamura, Taisuke, et al.
Publicado: (2017)

Correction: Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction
por: Aratani, Kenichi, et al.
Publicado: (2019)

Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2014)

Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2018)

Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2020)

Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma
por: Kiuchi, Jun, et al.
Publicado: (2019)

Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
por: Kamiya, Hajime, et al.
Publicado: (2023)

Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma
por: Hirajima, S, et al.
Publicado: (2013)

Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
por: Kawaguchi, T, et al.
Publicado: (2013)

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
por: Komatsu, S, et al.
Publicado: (2015)

Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2022)

Obesity paradox as a new insight from postoperative complications in gastric cancer
por: Kamiya, Hajime, et al.
Publicado: (2023)

The K–Cl Cotransporter KCC3 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma
por: Shiozaki, Atsushi, et al.
Publicado: (2014)

Differences of clinical features and outcomes between male and female elderly patients in gastric cancer
por: Arakawa, Hiroshi, et al.
Publicado: (2023)

A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2023)

Detection of fusion gene in cell-free DNA of a gastric synovial sarcoma
por: Ogino, Shinpei, et al.
Publicado: (2018)

Glutathione S‐transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma
por: Ogino, Shinpei, et al.
Publicado: (2018)

Na(+)/H(+) exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma
por: Ariyoshi, Yosuke, et al.
Publicado: (2016)

Circulating circERBB2 as a potential prognostic biomarker for gastric cancer: An investigative study
por: Nanishi, Kenji, et al.
Publicado: (2020)

Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2021)

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
por: Konishi, H, et al.
Publicado: (2012)

TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2021)

Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer
por: Fukami, Tomoyuki, et al.
Publicado: (2022)

Carbonic Anhydrase XII as an Independent Prognostic Factor in Advanced Esophageal Squamous Cell Carcinoma
por: Ochi, Fumiaki, et al.
Publicado: (2015)

Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma
por: Shiozaki, Atsushi, et al.
Publicado: (2017)

Persistent Postgastrectomy Hypoglycemia Unawareness in Patients With Gastric Cancer Unveiled by a Prospective Study
por: Kubota, Takeshi, et al.
Publicado: (2022)

Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma
por: Nishimura, Y, et al.
Publicado: (2013)

Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma
por: Takeshita, H, et al.
Publicado: (2010)

Circulating microRNAs in plasma of patients with gastric cancers
por: Tsujiura, M, et al.
Publicado: (2010)

Postoperative liver dysfunction is associated with poor long-term outcomes in patients with colorectal cancer: a retrospective cohort study
por: Sumiyoshi, Shutaro, et al.
Publicado: (2023)

Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma
por: Yamazato, Yuzo, et al.
Publicado: (2018)

Efficacy of a Hypotonic Treatment for Peritoneal Dissemination from Gastric Cancer Cells: An In Vivo Evaluation
por: Shiozaki, Atsushi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_67jdtotrio6dc4hholro7fl219